| Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More | Sarah de Crescenzo | 08/07/20 | National |
| Biogen to Pay Denali $1B to Partner on Parkinson’s Drug & Other Neuro Meds | Frank Vinluan | 08/06/20 | San Francisco |
| Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More | Frank Vinluan | 07/31/20 | National |
| Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort | Sarah de Crescenzo | 07/29/20 | San Diego |
| Thrive Adds $257M, Plans Pivotal Trial of Early Cancer Detection Test | Sarah de Crescenzo | 07/29/20 | National |
| Telehealth Firm AristaMD Adds $24M to Link Primary Docs With Specialists | Sarah de Crescenzo | 07/27/20 | San Diego |
| Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More | Sarah de Crescenzo | 07/24/20 | National |
| Acadia Halts Work on Depression Drug After Late-Stage Trial Failure | Sarah de Crescenzo | 07/21/20 | San Diego |
| Exalys Launches With $15M to Treat Postoperative Delirium & More | Sarah de Crescenzo | 07/17/20 | San Diego |
| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| Last Chance for Xconomy Awards Nominations – Deadline is Friday, July 17 | Editors | 07/15/20 | Boston |
| After Biologic COVID-19 Drug OK’d in India, Equillium Plans a US Test | Sarah de Crescenzo | 07/14/20 | San Diego |
| 3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments | Sarah de Crescenzo | 07/13/20 | National |
| Bio Roundup: Blackstone’s Billions, Biogen Finishes Filing, Novavax at “Warp Speed” & More | Sarah de Crescenzo | 07/10/20 | National |
| VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs | Sarah de Crescenzo | 07/09/20 | San Diego |
| Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine | Sarah de Crescenzo | 07/07/20 | National |
| PacBio CEO, CFO Plan Retirements and More People on the Move | Editors | 07/07/20 | National |
| MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy | Sarah de Crescenzo | 07/02/20 | San Diego |
| Roche Gets FDA OK for Injectable Version of Breast Cancer Drug | Sarah de Crescenzo | 06/29/20 | San Diego |
| FDA Again Dings Heron’s Opioid Alternative Over “Nonclinical Issues” | Sarah de Crescenzo | 06/29/20 | San Diego |
| Artiva Bio Raises $78M to Broaden Access to Cancer Cell Therapies | Sarah de Crescenzo | 06/26/20 | San Diego |
| Bio Roundup: Gilead’s Pionyr Grab, Relay to IPO, Unicorn Sana & More | Sarah de Crescenzo | 06/26/20 | National |
| La Jolla Pharma Steps In With Better Offer, Wins Tetraphase Bidding War | Frank Vinluan | 06/24/20 | San Diego |
| Reneo Readies for Global Test of Drug for Rare Mitochondrial Disease | Sarah de Crescenzo | 06/23/20 | San Diego |
| Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More | Frank Vinluan | 06/19/20 | National |
| Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs | Sarah de Crescenzo | 06/18/20 | San Diego |
| Frazier Launches Lassen to Advance Antibodies Against Fibrosis, Cancer | Sarah de Crescenzo | 06/17/20 | San Diego |
| Exec Search Underway at PacBio After CEO, CFO Announce Plans to Retire | Sarah de Crescenzo | 06/16/20 | San Francisco |
| FDA Reverses Authorization for Use of Antimalarials to Treat COVID-19 | Sarah de Crescenzo | 06/15/20 | National |
| Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More | Sarah de Crescenzo | 06/12/20 | National |
